The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wilson Jason Douglas since 2019.
The trader's CIK number is 1662395.
At the time of the last reporting, Wilson Jason Douglas was the Chief Financial Officer of Reata Pharmaceuticals Inc. (stock ticker symbol RETA).
Also see all insider trading activities at Reata Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | RETA | 0 | $0 | 142,000 | $15,182,470 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-12-16 | RETA | Sale | 10,000 | 203.99 | 2,039,890 |
| 2019-10-17 | RETA | Sale | 10,000 | 170.00 | 1,700,000 |
| 2019-10-14 | RETA | Sale | 15,000 | 100.00 | 1,500,000 |
| 2019-10-15 | RETA | Sale | 15,000 | 146.87 | 2,203,095 |
| 2019-08-15 | RETA | Sale | 4,000 | 73.28 | 293,136 |
| 2019-07-15 | RETA | Sale | 4,000 | 84.77 | 339,060 |
| 2019-06-17 | RETA | Sale | 4,000 | 83.52 | 334,060 |
| 2019-05-15 | RETA | Sale | 4,000 | 89.75 | 359,020 |
| 2019-04-15 | RETA | Sale | 4,000 | 83.97 | 335,892 |
| 2019-03-19 | RETA | Sale | 28,396 | 94.51 | 2,683,649 |
| 2019-03-15 | RETA | Sale | 4,000 | 93.62 | 374,468 |
| 2019-03-18 | RETA | Sale | 1,604 | 95.11 | 152,556 |
| 2019-02-15 | RETA | Sale | 4,000 | 85.44 | 341,760 |
| 2019-02-05 | RETA | Sale | 3,000 | 80.00 | 240,000 |
| 2019-01-31 | RETA | Sale | 6,135 | 80.00 | 490,800 |
| 2019-02-01 | RETA | Sale | 865 | 80.00 | 69,200 |
| 2019-01-15 | RETA | Sale | 4,000 | 71.27 | 285,064 |
| 2019-01-07 | RETA | Sale | 20,000 | 72.04 | 1,440,820 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wilson Jason Douglas (Chief Financial Officer of Reata Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.